Parkinson's is a disease with unknown causes. It destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor coordination are typical symptoms of Parkinson's.
Researchers at University of Bergen (UiB) in Norway discovered that medicine against asthma and blood pressure is linked to the risk of getting Parkinson's disease.
They found that while the use of asthma medicine halves the risk of getting Parkinson's, one type of medicine against high blood pressure doubles the risk.
"Our analysis of data from the whole Norwegian population has been decisive for the conclusion in this study," said Trond Riise, professor at the University of Bergen (UiB).
"Our discoveries may be the start of a totally new possible treatment for this serious disease. We expect that clinical studies will follow these discoveries," Riise added.
Researchers analysed more than 100 million Norwegian prescriptions ordered over the last 11 years in Norway.
In the study, the treatment of Parkinson's was linked to prescriptions of asthma medicine and the medicine for high blood pressure. It enabled the researchers to see the connection between medicine use and illness.
The Norwegian analysis was done after researchers at Harvard University in the US found these effects of the medicines in animal tests and in experiments with brain cells in the lab.
New breakthrough
- Causes of Parkinson’s disease is not know
- It destroys the brain cells that control body movements
- Shivering, stiff arms and legs and poor coordination are typical symptoms of Parkinson’s
- Researchers at University of Bergen found that the use of asthma medicine halves the risk of getting Parkinson’s
- The study also found that one type of medicine for high blood pressure doubles the risk of Parkinson’s
- Discoveries may be the start of a totally new possible treatment for Parkinson’s disease
- Results show that these different medicines had opposite effects on the risk of Parkinson’s
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)